tecvayli
janssen-cilag international n.v. - teclistamab - multiple myeloma - antineoplastična sredstva - tecvayli is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.
bortezomib teva 3,5 mg prašek za raztopino za injiciranje
teva b.v. - bortezomib - prašek za raztopino za injiciranje - bortezomib 3,5 mg / 1 viala - bortezomib
paxene
norton healthcare ltd. - paklitaksel - sarcoma, kaposi; carcinoma, non-small-cell lung; ovarian neoplasms; breast neoplasms - antineoplastična sredstva - paxene je indiciran za zdravljenje bolnikov z:• napredno za aidsom kaposi ' s sarkom (aids-cs), ki je ni pred liposomal anthracycline terapije;• metastatskim karcinom dojk (mbc), ki je ni, ali pa niso kandidati za standardne anthracycline-ki vsebujejo terapije;• napredno karcinom iz jajčnikov (aoc) ali z preostale bolezni (> 1 cm) po začetnem laparotomija, v kombinaciji z cisplatin kot prvo linijo zdravljenja;• metastatskim karcinom iz jajčnikov (moc) po izpadu platinum, ki vsebujejo kombinacijo terapija brez taxanes kot drugi liniji zdravljenja;• non-small cell karcinom pljuč (nsclc), ki niso kandidati za potencialno kurativno operacijo in/ali obsevanjem, v kombinaciji z cisplatin. omejeni podatki o učinkovitosti podpirajo to indikacijo (glejte poglavje 5).
calquence
astrazeneca ab - acalabrutinib - levkemija, limfocitna, kronična, b-celica - antineoplastic agents, protein kinase inhibitors, - calquence as monotherapy or in combination with obinutuzumab is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll). calquence as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukaemia (cll) who have received at least one prior therapy.
talvey
janssen-cilag international n.v. - talquetamab - multiple myeloma - antineoplastična sredstva - talvey is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least 3 prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti cd38 antibody and have demonstrated disease progression on the last therapy.
pamitor 60 mg koncentrat za raztopino za infundiranje
chiesi slovenija, d.o.o. - pamidronska kislina - koncentrat za raztopino za infundiranje - pamidronska kislina 50,4 mg / 4 ml - pamidronska kislina
taxol 6 mg/ml koncentrat za raztopino za infundiranje
bms Češka - paklitaksel - koncentrat za raztopino za infundiranje - paklitaksel 6 mg / 1 ml - paklitaksel
taxol 6 mg/ml koncentrat za raztopino za infundiranje
bms Češka - paklitaksel - koncentrat za raztopino za infundiranje - paklitaksel 6 mg / 1 ml - paklitaksel
taxol 6 mg/ml koncentrat za raztopino za infundiranje
bms Češka - paklitaksel - koncentrat za raztopino za infundiranje - paklitaksel 6 mg / 1 ml - paklitaksel
pamitor 90 mg koncentrat za raztopino za infundiranje
chiesi slovenija, d.o.o. - pamidronska kislina - koncentrat za raztopino za infundiranje - pamidronska kislina 75,6 mg / 6 ml - pamidronska kislina